call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Sexually Transmitted Disease Testing Market
Inquire Before Buying Request for Sample

Sexually Transmitted Disease Testing Market

Home Healthcare And Pharmaceutical Sexually Transmitted Disease Testing Market

SPECIAL OFFER : 25% Super Discount For All !

Sexually Transmitted Disease (STD) Testing Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Disease (Chlamydia, Syphilis, Gonorrhea, Hyper Simplex Virus Human Immunodeficiency Virus, Chancroid); By Location (Laboratory, Point of Care (PoC)); By Device (Laboratory Devices, Point of Care (PoC) Devices); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: January 2023
  • Report ID: BWC23024
  • Available Format: PDF
  • Page: 200

Report Overview

Increasing reimbursements for sexually transmitted diseases (STDs) testing across the countries, high prevalence and rise in incidences of STDs across the world, and implementation of national screening programs are projected to propel the expansion of Global Sexually Transmitted Diseases (STDs) Testing Market during the forecast period between 2023 and 2029.

Global Sexually Transmitted Disease Testing Market - Industry Trends & Forecast Report, 2029

Global sexually transmitted disease (STD) testing market size was estimated at USD 91.4 billion in 2022. During the forecast period between 2023 and 2029, the size of global sexually transmitted disease (STD) testing market is projected to grow at a CAGR of 6.2% reaching a value of USD 135.5 billion by 2029. Major growth drivers for global sexually transmitted disease testing market include increasing public awareness and patient education, global rise in the incidence of sexually transmitted illnesses, increasing patient awareness through education campaigns, and a surge in government activities. The prevalence and incidence of sexually transmitted illnesses have increased significantly during the previous decade. As the frequency of sexually transmitted illnesses increases, countries worldwide are focused on the deployment of national screening programs to expand the coverage of STD diagnosis. Also, the payment regulations for services related to STDs have been favorable. Technology advancements and developments in the diagnosis of STDs are also projected to boost market expansion. Increased national screening program implementation to increase STD diagnosis coverage will also boost the demand for STDs testing. These reasons are considerably driving the growth of the global STDs testing market.

Sexually Transmitted Disease Testing Market

Global Sexually Transmitted Disease Testing Market– Overview

Sexual health testing is a collection of diverse tests and procedures used to diagnose and detect sexually transmitted illnesses such as Chlamydia, Gonorrhea, Trichomonas, HIV, HSV, HCV, HPV, and others. For sexual health testing, four major types of testing are employed, including Culture/Isolation of Organisms, Molecular Test, Immunology Assay, and others. HIV can be diagnosed using one of three HIV tests: antibody testing, antigen/antibody tests, and nucleic acid tests (NAT). STD prevalence and incidence have risen considerably in the recent decade. As the prevalence of sexually transmitted illnesses rises, nations around the world are focusing on developing nationwide screening programs to increase the adoption of STD diagnostics coverage. Furthermore, reimbursement regulations for diagnostic services for STDs have been useful. These factors are significantly contributing to the growth of the global STDs diagnostics market.

Global Sexually Transmitted Disease Testing Market

Growth Drivers

High Prevalence & Rise in Incidences of STDs across the Globe

Sexually transmitted infections have a significant global influence on sexual and reproductive health. In 2019, teenagers and young adults aged 15 to 24 years constituted for more than 55% of reported cases of sexually transmitted infections. In 2020, the World Health Organization (WHO) recorded 374 million cases of one of four STIs. The most instances were acquired by Chlamydia (129 million), preceded by gonorrhea, syphilis, and trichomoniasis. In 2018, HPV infections were connected to 570,000 cases of cervical cancer and over 311,000 deaths from the disease. According to the Cleveland Clinic, about 20 million new STD infections occur each year. An estimated 820,000 persons died from hepatitis B in 2019, the majority from hepatocellular cancer and cirrhosis. The frequency of all these infections among people is steadily increasing because of unprotected sex, a lack of understanding, and multiple partner intimacy. As a result, testing for STDs is becoming increasingly prevalent, boosting the market growth.

Restraints

Social Stigma Associated with Patients Visiting Specialized STD Clinics

Numerous STDs are socially stigmatized. In other words, people are judged or chastised for having STDs and other diseases. The STD stigma is usually exceedingly strong. HIV stigma refers to negative attitudes and ideas held towards HIV-positive people. It is the unfavorable views that result from classifying someone as a member of a socially unacceptable group. Because of a lack of information and awareness, as well as antiquated attitudes, people are terrified of obtaining HIV. Furthermore, many individuals assume that HIV is a sickness that affects just certain ethnicities. This leads to moral judgments towards HIV-positive people. HIV patients internalize the stigma they face and develop a bad self-image. If their HIV status is exposed, they may be terrified of being judged or discriminated against. Hence, such factors are anticipated to restrain the market growth.

Impact of COVID-19 on Global Sexually Transmitted Disease Testing Market

COVID-19 had a detrimental impact on the STD (sexually transmitted disease) testing market. Due to disruptions in healthcare and STD testing facilities, the CDC (Centers for Disease Control and Prevention) observed a decline in STD testing during the early months of COVID-19. Few members may have unwittingly disseminated the virus due to inadequate testing and diagnosis. As a result, even though the transmission of STDs rose during the pandemic, the market value declined due to the decrease in testing. STD testing surged once the lockdown and travel ban were lifted, and the market is projected to boost the expansion of market growth.

Global Sexually Transmitted Disease Testing Market

Segmental Coverage

Global Sexually Transmitted Disease Testing Market – By Disease

By disease, global sexually transmitted disease testing market is divided into Chlamydia, Syphilis, Gonorrhoea, Hyper Simplex Virus, Human Immunodeficiency Virus, and Chancroid segments. The Chlamydia segment accounted for the highest market share in 2022. However, the HPV infection segment is expected to skyrocket during the forecast period. The Centers for Disease Control and Prevention (CDC) received 616,392 complaints of gonorrhea in 2019, making it the second most common reportable disease in the US.

Global Sexually Transmitted Disease Testing Market – By Location

Based on location, global sexually transmitted disease testing market is bifurcated in Laboratory and Point of Care (PoC). In 2022, the laboratory testing segment held a higher market share, but point-of-care testing is predicted to rise at the quickest rate in the years ahead. Laboratory testing includes commercial/private labs and public health labs. Laboratory testing is a time-consuming but more exact procedure that involves commercial/private labs as well as public health labs. Likewise, point-of-care testing segment includes testing kits, is faster, the results may be less exact. However, bedside testing or mobile testing that allows for rapid healthcare provision for patients is capturing market share. There has been a major transition from traditional laboratory tests to rapid and easy PoC tests, due to the benefits provided by point of care testing equipment.

Sexually Transmitted Disease Testing Market Size

Global Sexually Transmitted Disease Testing Market – By Device

Based on location, global sexually transmitted disease testing market is bifurcated laboratory Devices and Point of Care (PoC) Devices segments. The laboratory devices segment is subdivided into Thermal Cyclers PCR, Lateral Flow Readers- Immune Chromatographic Arrays, Flow Cytometers, Differential Light Scattering Machines, and Absorbance Micro Plate Reader-Enzyme-Linked Immunosorbent Assay (ELISA). During the forecast period, PCR for STD diagnosis is expected to hold the highest market share. Phone chips (microfluidics and ICT) and portable/bench top/rapid diagnostic kits are examples of point of care testing equipment. The point-of-care testing equipment technological advancements result in accurate and trustworthy results. In 2022, the market for portable POC testing devices dominated the market.

Sexually Transmitted Disease Testing Market Share

Global Sexually Transmitted Disease Testing Market – By Region

Geographically, global sexually transmitted disease testing market covers major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The Asia-Pacific region held the highest market share in 2022. A rise in the number of STI cases, a surge in the youth population, a lack of knowledge, and increased government activities are driving the Asia-Pacific STD testing market. North America, on the other hand, will see considerable growth in the next years because of the presence of important companies, the availability of technologically advanced products, and the increasing acceptance of point of care testing.

Competitive Landscape

Major players operating in global sexually transmitted disease testing market include Abbott Laboratories, BioMérieux, Inc., Becton Dickinson Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., Diasorin Molecular LLC, Roche Holding AG, Orasure Technologies, Inc., Thermo Fisher Scientific Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, and Merck and Co. Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In May 2022 – Becton, Dickinson and Group launched a new, fully automated, high-throughput infectious disease molecular diagnostics platform, the BD COR MX instrument, in the US. The test is a single test that detects the three most common non-viral STIs: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginitis (TV). These three STIs can result in a variety of negative patient outcomes, ranging from pregnancy difficulties to increased HIV risk.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, The Netherlands, Belgium, NORDIC Countries, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Philippines, Vietnam, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Peru, Colombia, Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Qatar, Kuwait, Iran, South Africa, Nigeria, Kenya, Egypt, Morocco, Algeria, Rest of Middle East & Africa)

Product/ Service Segmentation

Disease, Location, Drive, Region

Key Players

Abbott Laboratories, BioMérieux, Inc., Becton Dickinson Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., Diasorin Molecular LLC, Roche Holding AG, Orasure Technologies, Inc., Thermo Fisher Scientific Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Merck and Co. Inc.

 

By Disease

  • Chlamydia

  • Syphilis

  • Gonorrhoea

  • Hyper Simplex Virus

  • Human Immunodeficiency Virus

  • Chancroid

By Location

  • Laboratory

  • Point of Care (POC)

By Device

  • Laboratory Devices

  • Point of Care (PoC) Devices

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Sexually Transmitted Disease Testing Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. High Prevalence & Rise in Incidences of STD across the Globe
        2. Implementation of National Screening Programs
        3. Supporting Reimbursement of STDs Testing
      2. Restraints
        1. Social Stigma Associated with Patients Visiting Specialized STD Clinics
        2. Huge Protection of Patients Infected with STDs in Remotes Areas
      3. Opportunities
        1. Decrease In Number of Visits to Government Clinics
        2. National Screening Programs Across the Globe
        3. Niche Opportunities for Technology and POC Test Providers in an Emerging Economy
      4. Challenges
        1. Stringent Regulations
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Sexually Transmitted Disease Testing Market Overview
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Disease
        1. Chlamydia
        2. Syphilis
        3. Gonorrhoea
        4. Hyper Simplex Virus
        5. Human Immunodeficiency Virus
        6. Chancroid
        7. Others
      2. By Location
        1. Laboratory
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care (POC)
      3. By Device
        1. Laboratory Devices
          1. Thermal Cyclers PCR
          2. Lateral Flow Readers- Immune Chromatographic Arrays
          3. Flow Cytometers
          4. Differential Light Scattering Machines
          5. Absorbance Micro Plate Reader- Enzyme- Linked Immunosorbent Assay (ELISA)
          6. Others
        2. Point of Care (POC) Devices
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific
        4. Latin America
        5. Middle East and Africa
  5. North America Sexually Transmitted Disease Testing Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Disease
      2. By Location
      3. By Device
      4. By Country
        1. US
          1. By Disease
          2. By Location
          3. By Device
        2. Canada
          1. By Disease
          2. By Location
          3. By Device
  6. Europe Sexually Transmitted Disease Testing Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Disease
      2. By Location
      3. By Device
      4. By Country
        1. Germany
          1. By Disease
          2. By Location
          3. By Device
        2. UK
          1. By Disease
          2. By Location
          3. By Device
        3. Italy
          1. By Disease
          2. By Location
          3. By Device
        4. France
          1. By Disease
          2. By Location
          3. By Device
        5. Spain
          1. By Disease
          2. By Location
          3. By Device
        6. The Netherlands
          1. By Disease
          2. By Location
          3. By Device
        7. Rest of Europe
          1. By Disease
          2. By Location
          3. By Device
  7. Asia-Pacific Sexually Transmitted Disease Testing Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Disease
      2. By Location
      3. By Device
      4. By Country
        1. China
          1. By Disease
          2. By Location
          3. By Device
        2. India
          1. By Disease
          2. By Location
          3. By Device
        3. Japan
          1. By Disease
          2. By Location
          3. By Device
        4. South Korea
          1. By Disease
          2. By Location
          3. By Device
        5. Australia & New Zealand
          1. By Disease
          2. By Location
          3. By Device
        6. Indonesia
          1. By Disease
          2. By Location
          3. By Device
        7. Malaysia
          1. By Disease
          2. By Location
          3. By Device
        8. Singapore
          1. By Disease
          2. By Location
          3. By Device
        9. Philippines
          1. By Disease
          2. By Location
          3. By Device
        10. Vietnam
          1. By Disease
          2. By Location
          3. By Device
        11. Rest of APAC
          1. By Disease
          2. By Location
          3. By Device
  8. Latin America Sexually Transmitted Disease Testing Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Disease
      2. By Location
      3. By Device
      4. By Country
        1. Brazil
          1. By Disease
          2. By Location
          3. By Device
        2. Mexico
          1. By Disease
          2. By Location
          3. By Device
        3. Argentina
          1. By Disease
          2. By Location
          3. By Device
        4. Peru
          1. By Disease
          2. By Location
          3. By Device
        5. Colombia
          1. By Disease
          2. By Location
          3. By Device
        6. Rest of LATAM
          1. By Disease
          2. By Location
          3. By Device
  9.  Middle East & Africa Sexually Transmitted Disease Testing Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Disease
      2. By Location
      3. By Device
      4. By Country
        1. Saudi Arabia
          1. By Disease
          2. By Location
          3. By Device
        2. UAE
          1. By Disease
          2. By Location
          3. By Device
        3. Qatar
          1. By Disease
          2. By Location
          3. By Device
        4. Kuwait
          1. By Disease
          2. By Location
          3. By Device
        5. South Africa
          1. By Disease
          2. By Location
          3. By Device
        6. Nigeria
          1. By Disease
          2. By Location
          3. By Device
        7. Algeria
          1. By Disease
          2. By Location
          3. By Device
        8. Rest of MEA
          1. By Disease
          2. By Location
          3. By Device
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Sexually Transmitted Disease Testing Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Sexually Transmitted Disease Testing Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Abbott Laboratories
    2. BioMérieux, Inc.
    3. Becton Dickinson Company
    4. Danaher Corporation
    5. Bio-Rad Laboratories, Inc.
    6. Hologic, Inc.
    7. Diasorin Molecular LLC
    8. Roche Holding AG
    9. Orasure Technologies, Inc.,
    10. Thermo Fisher Scientific Inc.
    11. AccuBioTech Co. Ltd.
    12. AdvaCare Pharma
    13. BIOGENIX Inc. Pvt. Ltd.
    14. CTK Biotech Inc.
    15. Everlywell Inc.
    16. F. Hoffmann La Roche Ltd.
    17. Gilead Sciences Inc.
    18. GlaxoSmithKline Plc
    19. Merck and Co. Inc.
    20. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation

 

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

List of Figures

Figure 1      Global Sexually Transmitted Disease Testing Market Segmentation

Figure 2      Global Sexually Transmitted Disease Testing Market Value Chain Analysis

Figure 3      Company Market Share Analysis, 2022

Figure 4      Global Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 5      Global Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 6      Global Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 7      Global Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 8      Global Sexually Transmitted Disease Testing Market Share, By Region, By Value, 2019–2029

Figure 9      North America Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 10    North America Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 11    North America Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 12    North America Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 13    North America Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029

Figure 14    US Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 15    US Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 16    US Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 17    US Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 18    Canada Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 19    Canada Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 20    Canada Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 21    Canada Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 22    Europe Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 23    Europe Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 24    Europe Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 25    Europe Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 26    Europe Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029

Figure 27    Germany Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 28    Germany Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 29    Germany Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 30    Germany Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 31    UK Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 32    UK Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 33    UK Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 34    UK Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 35    Italy Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 36    Italy Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 37    Italy Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 38    Italy Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 39    France Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 40    France Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 41    France Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 42    France Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 43    Spain Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 44    Spain Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 45    Spain Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 46    Spain Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 47    The Netherlands Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 48    The Netherlands Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 49    The Netherlands Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 50    The Netherlands Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 51    Rest of Europe Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 52    Rest of Europe Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 53    Rest of Europe Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 54    Rest of Europe Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 55    Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 56    Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 57    Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 58    Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 59    Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029

Figure 60    China Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 61    China Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 62    China Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 63    China Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 64    India Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 65    India Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 66    India Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 67    India Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 68    Japan Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 69    Japan Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 70    Japan Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 71    Japan Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 72    South Korea Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 73    South Korea Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 74    South Korea Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 75    South Korea Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 76    Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 77    Australia & New Zealand Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 78    Australia & New Zealand Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 79    Australia & New Zealand Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 80    Indonesia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 81    Indonesia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 82    Indonesia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 83    Indonesia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 84    Malaysia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 85    Malaysia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 86    Malaysia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 87    Malaysia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 88    Singapore Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 89    Singapore Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 90    Singapore Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 91    Singapore Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 92    Philippines Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 93    Philippines Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 94    Philippines Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 95    Philippines Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 96    Vietnam Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 97    Vietnam Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 98    Vietnam Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 99    Vietnam Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 100   Rest of APAC Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 101   Rest of APAC Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 102   Rest of APAC Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 103   Rest of APAC Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 104   Latin America Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 105   Latin America Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 106   Latin America Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 107   Latin America Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 108   Latin America Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029

Figure 109   Brazil Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 110   Brazil Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 111   Brazil Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 112   Brazil Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 113   Mexico Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 114   Mexico Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 115   Mexico Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 116   Mexico Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 117   Argentina Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 118   Argentina Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 119   Argentina Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 120   Argentina Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 121   Peru Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 122   Peru Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 123   Peru Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 124   Peru Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 125   Colombia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 126   Colombia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 127   Colombia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 128   Colombia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 129   Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 130   Rest of LATAM Sexually Transmitted Disease Testing Market Share, By Disease. By Value, 2019–2029

Figure 131   Rest of LATAM Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 132   Rest of LATAM Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 133   Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 134   Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 135   Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 136   Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 137   Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029

Figure 138   Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 139   Saudi Arabia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 140   Saudi Arabia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 141   Saudi Arabia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 142   UAE Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 143   UAE Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 144   UAE Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 145   UAE Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 146   Qatar Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 147   Qatar Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 148   Qatar Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 149   Qatar Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 150   Kuwait Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 151   Kuwait Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 152   Kuwait Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 153   Kuwait Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 154   South Africa Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 155   South Africa Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 156   South Africa Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 157   South Africa Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 158   Nigeria Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 159   Nigeria Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 160   Nigeria Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 161   Nigeria Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 162   Algeria Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 163   Algeria Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 164   Algeria Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 165   Algeria Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

Figure 166   Rest of MEA Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029

Figure 167   Rest of MEA Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029

Figure 168   Rest of MEA Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029

Figure 169   Rest of MEA Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029

 

 

List of Tables

Table 1       Global Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 2       Global Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 3       Global Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 4       Global Sexually Transmitted Disease Testing Market Size, By Region, By Value, 2019–2029

Table 5       North America Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 6       North America Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 7       North America Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 8       North America Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029

Table 9       US Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 10     US Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 11     US Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 12     Canada Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 13     Canada Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 14     Canada Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 15     Europe Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 16     Europe Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 17     Europe Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 18     Europe Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029

Table 19     Germany Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 20     Germany Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 21     Germany Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 22     UK Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 23     UK Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 24     UK Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 25     Italy Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 26     Italy Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 27     Italy Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 28     France Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 29     France Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 30     France Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 31     Spain Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 32     Spain Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 33     Spain Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 34     The Netherlands Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 35     The Netherlands Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 36     The Netherlands Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 37     Rest of Europe Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 38     Rest of Europe Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 39     Rest of Europe Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 40     Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 41     Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 42     Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 43     Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029

Table 44     China Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 45     China Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 46     China Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 47     India Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 48     India Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 49     India Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 50     Japan Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 51     Japan Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 52     Japan Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 53     South Korea Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 54     South Korea Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 55     South Korea Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 56     Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 57     Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 58     Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 59     Indonesia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 60     Indonesia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 61     Indonesia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 62     Malaysia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 63     Malaysia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 64     Malaysia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 65     Singapore Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 66     Singapore Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 67     Singapore Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 68     Philippines Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 69     Philippines Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 70     Philippines Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 71     Vietnam Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 72     Vietnam Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 73     Vietnam Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 74     Rest of APAC Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 75     Rest of APAC Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 76     Rest of APAC Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 77     Latin America Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 78     Latin America Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 79     Latin America Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 80     Latin America Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029

Table 81     Brazil Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 82     Brazil Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 83     Brazil Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 84     Mexico Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 85     Mexico Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 86     Mexico Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 87     Argentina Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 88     Argentina Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 89     Argentina Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 90     Peru Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 91     Peru Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 92     Peru Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 93     Colombia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 94     Colombia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 95     Colombia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 96     Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 97     Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 98     Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 99     Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 100    Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 101    Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 102    Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029

Table 103    Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 104    Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 105    Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 106    UAE Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 107    UAE Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 108    UAE Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 109    Qatar Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 110    Qatar Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 111    Qatar Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 112    Kuwait Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 113    Kuwait Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 114    Kuwait Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 115    South Africa Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 116    South Africa Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 117    South Africa Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 118    Nigeria Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 119    Nigeria Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 120    Nigeria Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 121    Algeria Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 122    Algeria Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 123    Algeria Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 124    Rest of MEA Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029

Table 125    Rest of MEA Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029

Table 126    Rest of MEA Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029

Table 127    Abbott Laboratories Company Overview

Table 128    Abbott Laboratories Financial Overview

Table 129    BioMérieux, Inc. Company Overview

Table 130    BioMérieux, Inc. Financial Overview

Table 131    Becton Dickinson Company Overview

Table 132    Becton Dickinson Company Financial Overview

Table 133    Danaher Corporation Company Overview

Table 134    Danaher Corporation Financial Overview

Table 135    Bio-Rad Laboratories, Inc. Company Overview

Table 136    Bio-Rad Laboratories, Inc. Financial Overview

Table 137    Hologic, Inc. Company Overview

Table 138    Hologic, Inc. Financial Overview

Table 139    Diasorin Molecular LLC Company Overview

Table 140    Diasorin Molecular LLC Financial Overview

Table 141    Roche Holding AG Company Overview

Table 142    Roche Holding AG Financial Overview

Table 143    Orasure Technologies, Inc. Company Overview

Table 144    Orasure Technologies, Inc. Financial Overview

Table 145    Thermo Fisher Scientific Inc. Company Overview

Table 146    Thermo Fisher Scientific Inc. Financial Overview

Table 147    AccuBioTech Co. Ltd. Company Overview

Table 148    AccuBioTech Co. Ltd. Financial Overview

Table 149    AdvaCare Pharma Company Overview

Table 150    AdvaCare Pharma Financial Overview

Table 151    BIOGENIX Inc. Pvt. Ltd. Company Overview

Table 152    BIOGENIX Inc. Pvt. Ltd. Financial Overview

Table 153    CTK Biotech Inc. Company Overview

Table 154    CTK Biotech Inc. Financial Overview

Table 155    Everlywell Inc. Company Overview

Table 156    Everlywell Inc. Financial Overview

Table 157    F. Hoffmann La Roche Ltd. Company Overview

Table 158    F. Hoffmann La Roche Ltd. Financial Overview

Table 159    Gilead Sciences Inc. Company Overview

Table 160    Gilead Sciences Inc. Financial Overview

Table 161    GlaxoSmithKline Plc Company Overview

Table 162    GlaxoSmithKline Plc Financial Overview

Table 163    Merck and Co. Inc. Company Overview

Table 164    Merck and Co. Inc. Financial Overview

Market Segmentation

By Disease

  • Chlamydia

  • Syphilis

  • Gonorrhoea

  • Hyper Simplex Virus

  • Human Immunodeficiency Virus

  • Chancroid

By Location

  • Laboratory

  • Point of Care (POC)

By Device

  • Laboratory Devices

  • Point of Care (PoC) Devices

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Major factors driving the growth of global Sexually Transmitted Disease Testing Market include high prevalence & rise in incidences of STD across the globe, implementation of national screening programs, and supporting reimbursement of STDs testing.
Ans: In 2022, global Sexually Transmitted Disease Testing Market size was estimated at USD 91.4 billion.
Ans: Key players in global Sexually Transmitted Disease Testing Market include Abbott Laboratories, BioMérieux, Inc., Becton Dickinson Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., Diasorin Molecular LLC, Roche Holding AG, Orasure Technologies, Inc., Thermo Fisher Scientific Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, and Merck and Co. Inc.
Ans: The laboratory testing segment is expected to hold a higher market share in global Sexually Transmitted Disease Testing Market by location.